5th September 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

*Refresh the page if the below document does not appear.

Sarten DSR Capsules, 47000 Capsules Seized from Pharma Company in HP

After the Himachal Pradesh Drug Regulatory Authority received information about some infamous activities, a pharmaceutical company in the state has come under scrutiny.

Bayer to pay USD 40 million to settle US whistleblower claims related to three drugs

U.S. Department of Justice announced that Bayer AG had reached an agreement to pay $40 million to resolve claims that it used kickbacks and made false statements about three prescription drugs.

USFDA approved Vertex's Orkambi for use in 12 to 24 month old cystic fibrosis patients

USFDA has authorised the use of Orkambi (lumacaftor/ivacaftor) in children with cystic fibrosis (CF) who are homozygous for the F508del mutation (F/F genotype) and are between the ages of 12 and 24 months.

Merck offers a 5-year review of Keytruda's groundbreaking lung cancer trials

Frontline nonsquamous non-small cell lung cancer patients treated with Merck’s Keytruda had a five-year survival rate of 19.4%, compared to a 5% five-year survival rate with chemotherapy in the past.

Aston Sci. receives approval from USFDA to start a phase 2 trial for breast cancer

USFDA has granted IND approval to Aston Sci. Inc., a clinical stage biopharmaceutical company specialising in the clinical development of therapeutic cancer vaccines, for AST-301, its flagship product, for a phase 2 clinical trial.

Futura's topical erectile dysfunction therapy reached phase 3, sparking a race to FDA

Phase 3 data on the topical ED treatment MED3000 from Futura Medical have been released, paving the way for the company to request FDA approval of the treatment as an over-the-counter drug by the end of the month.

A booster shot for Gujarat companies: Bulk drug park

The establishment of a bulk drug park in Jambusar has received preliminary approval in Gujarat, and the state’s pharmaceutical industry anticipates that the park will be operational in three years.

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.

Update profile

Please update your profile to keep using the website

Start chat
Need Help?
PharmaState Academy
Hello, how can we help you?